Cardiac Monitoring & Rhythm Management Devices Market by Type [Cardiac Monitoring (ECG, Ambulatory Monitors), Cardiac Rhythm Management [Pacemaker (Single, Leadless), Defibrillator (AED)], Application [Arrhythmia], End User [Hospital] - Global Forecast to

The global cardiac monitoring and cardiac rhythm management devices market is projected to reach USD 37.88 billion by 2031, up from USD 27.90 billion in 2026, growing at a CAGR of 6.3% over the forecast period. Market growth is driven by factors such as rising public awareness campaigns and screening programs aimed at early detection of cardiovascular diseases, which contribute to growing demand for cardiac monitoring devices, especially in high-risk populations. On the other hand, the adoption of remote monitoring and telemedicine technologies raises concerns about data security and patient privacy, which may hinder patient acceptance and adoption of these devices.

“The implantable cardioverter defibrillators accounted for the largest market share in the cardiac rhythm management device market, during the forecast period.”

By type, cardiac rhythm management devices in the market are classified into implantable cardioverter defibrillators and external defibrillators. In 2025, implantable cardioverter defibrillators accounted for a sizable market share because they provide continuous protection against sudden cardiac arrest by continuously monitor the heart's rhythm and deliver appropriate therapy when needed, protecting against sudden cardiac arrest. This constant monitoring and intervention offer round-the-clock protection for patients at risk of life-threatening arrhythmias, whereas external defibrillators are typically used for acute interventions in emergencies. Likewise, Implantable defibrillators are implanted surgically or via minimally invasive procedures in patients at high risk of sudden cardiac death due to underlying cardiac conditions such as ventricular arrhythmias or cardiomyopathy. They are intended for long-term use and are suitable for patients who require ongoing arrhythmia management. In contrast, external defibrillators, such as automated external defibrillators (AEDs) or manual defibrillators used in hospitals, are used mainly for emergency resuscitation in cases of cardiac arrest.

The home care settings are projected to register the highest CAGR during the forecast period.”

In the cardiac monitoring and rhythm management devices market, the home care segment is the fastest-growing end user due to the growing shift toward remote patient monitoring and home-based cardiac care. Advances in wearable, portable, and connected devices enable continuous monitoring and rhythm management outside traditional clinical settings, improving patient convenience and outcomes. Additionally, rising prevalence of chronic cardiac conditions, an aging population, and efforts to reduce hospitalizations and healthcare costs are further accelerating the adoption of these devices in home care environments.

“The North American region accounted for the highest share.”

The global cardiac monitoring and cardiac rhythm management devices market is divided into four regions: North America, Asia-Pacific, Europe, and the Rest of the World. According to the regional analysis, the North American region is likely to retain a significant market share in 2025 and beyond. The North American market is being propelled by rising cases of heart disease, increased healthcare expenditure, and greater awareness of early disease diagnosis.

The primary interviews conducted for this report can be categorized as follows:

• By Company Type: Tier 1 - 32%, Tier 2 - 44%, and Tier 3 - 24%
• By Designation: C-level - 30%, D-level - 34%, and Others - 36%
• By Region: North America - 40%, Europe - 28%, Asia Pacific - 20%, and the Rest of the World – 12%

The prominent players in the GE HealthCare (US), Koninklijke Philips N.V. (Netherlands), Boston Scientific Corporation (US), Baxter (US), Medtronic (Ireland), Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China), Abbott (US), Stryker (US), NIHON KOHDEN CORPORATION (Japan), MicroPort Scientific Corporation (China), FUKUDA DENSHI (Japan), OSI Systems, Inc. (US), iRhythm Inc. (US), Lepu Medical Technology (Beijing) Co., Ltd. (China), and AliveCor, Inc. (US) among others.

Research Coverage

This report studies the Cardiac monitoring and cardiac rhythm management devices market based on type, application, end user, and region. It also covers the factors affecting market growth, analyzes the various opportunities and challenges in the market, and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micro markets by their individual growth trends and forecasts market segment revenue for five central regions (and the respective countries in these regions).

Reasons to Buy the Report

The report will enable established firms as well as entrants/smaller firms to gauge the market pulse, which, in turn, will help them garner a larger market share. Firms purchasing the report could use one or a combination of the following strategies to strengthen their market presence.

This report provides insights into the following pointers:

• Analysis of key drivers (rapidly expanding global geriatric population and subsequent surge in cardiac diseases, increasing incidence of lifestyle and cardiovascular diseases), restraints (rapidly expanding global geriatric population and subsequent surge in cardiac diseases
• Increasing incidence of lifestyle and cardiovascular diseases), opportunities (untapped growth potential in emerging markets), and challenges (frequent product recalls) influencing the growth of the cardiac monitoring and cardiac rhythm management devices market

Market Penetration: Comprehensive information on the product portfolios offered by the top players in the Cardiac monitoring and cardiac rhythm management devices market

Product Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and product developments in the Cardiac monitoring and cardiac rhythm management devices market

Market Development: Comprehensive information on lucrative emerging regions

Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the Cardiac monitoring and cardiac rhythm management devices market

Competitive Assessment: In-depth assessment of market segments, growth strategies, revenue analysis, and products of the leading market players Show more